Association of Adipokines with Development and Progression of Nonalcoholic Fatty Liver Disease
Chrysoula Boutari (Boutari C), Nikolaos Perakakis (Perakakis N), Christos Socrates Mantzoros (Mantzoros CS)
Endocrinol Metab. 2018;33(1):33-43.   Published online 2018 Mar 21     DOI:
Citations to this article as recorded by Crossref logo
Long-term abuse of a high-carbohydrate diet is as harmful as a high-fat diet for development and progression of liver injury in a mouse model of NAFLD/NASH
Simona Pompili, Antonella Vetuschi, Eugenio Gaudio, Alessandra Tessitore, Roberta Capelli, Edoardo Alesse, Giovanni Latella, Roberta Sferra, Paolo Onori
Nutrition.2020; 75-76: 110782.     CrossRef
Targeted Analysis of Three Hormonal Systems Identifies Molecules Associated with the Presence and Severity of NAFLD
Stergios A Polyzos, Nikolaos Perakakis, Chrysoula Boutari, Jannis Kountouras, Wael Ghaly, Athanasios D Anastasilakis, Asterios Karagiannis, Christos S Mantzoros
The Journal of Clinical Endocrinology & Metabolism.2020; 105(3): e390.     CrossRef
Inflammatory Mechanisms of HCC Development
Maria Grazia Refolo, Caterina Messa, Vito Guerra, Brian Irving Carr, Rosalba D’Alessandro
Cancers.2020; 12(3): 641.     CrossRef
Mechanisms of Fibrosis Development in Nonalcoholic Steatohepatitis
Robert F. Schwabe, Ira Tabas, Utpal B. Pajvani
Gastroenterology.2020; 158(7): 1913.     CrossRef
Visceral-to-Subcutaneous Abdominal Fat Ratio Is Associated with Nonalcoholic Fatty Liver Disease and Liver Fibrosis
Chan-Hee Jung, Eun-Jung Rhee, Hyemi Kwon, Yoosoo Chang, Seungho Ryu, Won-Young Lee
Endocrinology and Metabolism.2020; 35(1): 165.     CrossRef
Alpha-syntrophin deficiency protects against non-alcoholic steatohepatitis associated increase of macrophages, CD8+ T-cells and galectin-3 in the liver
Lisa Rein-Fischboeck, Elisabeth M. Haberl, Ganimete Bajraktari, Susanne Feder, Rebekka Pohl, Elke Eggenhofer, Christa Buechler
Experimental and Molecular Pathology.2020; 113: 104363.     CrossRef
Targeting of Secretory Proteins as a Therapeutic Strategy for Treatment of Nonalcoholic Steatohepatitis (NASH)
Kyeongjin Kim, Kook Hwan Kim
International Journal of Molecular Sciences.2020; 21(7): 2296.     CrossRef
Non-Alcoholic Fatty Liver Disease Treatment in Patients with Type 2 Diabetes Mellitus; New Kids on the Block
Vasilios G. Athyros, Stergios A. Polyzos, Jiannis Kountouras, Niki Katsiki, Panagiotis Anagnostis, Michael Doumas, Christos S. Mantzoros
Current Vascular Pharmacology.2020; 18(2): 172.     CrossRef
High body mass index hinders fibrosis improvement in patients receiving long‐term tenofovir therapy in hepatitis B virus‐related cirrhosis
Young Eun Chon, Kyu Sik Jung, Yeonjung Ha, Mi Na Kim, Joo Ho Lee, Seong Gyu Hwang, Sang Hoon Ahn, Do Young Kim, Kwang‐Hyub Han, Jun Yong Park
Journal of Viral Hepatitis.2020;[Epub]     CrossRef
The role of omics in the pathophysiology, diagnosis and treatment of non-alcoholic fatty liver disease
Nikolaos Perakakis, Konstantinos Stefanakis, Christos S. Mantzoros
Metabolism.2020; : 154320.     CrossRef
The Selective Peroxisome Proliferator‐Activated Receptor Gamma Modulator CHS‐131 Improves Liver Histopathology and Metabolism in a Mouse Model of Obesity and Nonalcoholic Steatohepatitis
Nikolaos Perakakis, Aditya Joshi, Natia Peradze, Konstantinos Stefanakis, Georgia Li, Michael Feigh, Sanne Skovgard Veidal, Glenn Rosen, Michael Fleming, Christos S. Mantzoros
Hepatology Communications.2020;[Epub]     CrossRef
Osteocalcin and osteoprotegerin levels and their relationship with adipokines and proinflammatory cytokines in children with nonalcoholic fatty liver disease
Doaa El Amrousy, Dalia El-Afify
Cytokine.2020; 135: 155215.     CrossRef
Effects of sodium-glucose co-transporter-2 (SGLT2) inhibitors on non-alcoholic fatty liver disease/non-alcoholic steatohepatitis: Ex quo et quo vadimus?
Niki Katsiki, Nikolaos Perakakis, Christos Mantzoros
Metabolism.2019; 98: iii.     CrossRef
Role of Soluble Adiponectin Receptor 2 in Non-Alcoholic Fatty Liver Disease in Children
Gulsah Kaya Aksoy, Reha Artan, Cihat Aksoy, Sebahat Özdem, Atike Atalay, Aygen Yılmaz
Pediatric Gastroenterology, Hepatology & Nutrition.2019; 22(5): 470.     CrossRef
Determinants of ectopic liver fat in metabolic disease
Anja Bosy-Westphal, Wiebke Braun, Viktoria Albrecht, Manfred J. Müller
European Journal of Clinical Nutrition.2019; 73(2): 209.     CrossRef
Involvement of the hepatic branch of the vagus nerve in the regulation of plasma adipokine levels in rats fed a high-fructose diet
Naoto Hashimoto, Manabu Wakagi, Katsunari Ippoushi, Yuko Takano-Ishikawa
The Journal of Nutritional Biochemistry.2019; 71: 90.     CrossRef
Fat and Sugar—A Dangerous Duet. A Comparative Review on Metabolic Remodeling in Rodent Models of Nonalcoholic Fatty Liver Disease
Ines C.M. Simoes, Justyna Janikiewicz, Judith Bauer, Agnieszka Karkucinska-Wieckowska, Piotr Kalinowski, Agnieszka Dobrzyń, Andrzej Wolski, Maciej Pronicki, Krzysztof Zieniewicz, Paweł Dobrzyń, Marcin Krawczyk, Hans Zischka, Mariusz R. Wieckowski, Yaiza P
Nutrients.2019; 11(12): 2871.     CrossRef
Childhood obesity: increased risk for cardiometabolic disease and cancer in adulthood
Susann Weihrauch-Blüher, Peter Schwarz, Jan-Henning Klusmann
Metabolism.2019; 92: 147.     CrossRef
Effects of moderate-intensity continuous training and high-intensity interval training on serum levels of Resistin, Chemerin and liver enzymes in Streptozotocin-Nicotinamide induced Type-2 diabetic rats
Parastesh Mohammad, Khosravi Zadeh Esfandiar, Saremi Abbas, Rekabtalae Ahoora
Journal of Diabetes & Metabolic Disorders.2019; 18(2): 379.     CrossRef
Obesity and nonalcoholic fatty liver disease: From pathophysiology to therapeutics
Stergios A. Polyzos, Jannis Kountouras, Christos S. Mantzoros
Metabolism.2019; 92: 82.     CrossRef
The Latest Insights into Adipokines in Diabetes
Won Kon Kim, Kwang-Hee Bae, Sang Chul Lee, Kyoung-Jin Oh
Journal of Clinical Medicine.2019; 8(11): 1874.     CrossRef
Postprandial leptin and adiponectin in response to sugar and fat in obese and normal weight individuals
M. A. Larsen, V. T. Isaksen, E. J. Paulssen, R. Goll, J. R. Florholmen
Endocrine.2019; 66(3): 517.     CrossRef
First demonstration of protective effects of purified mushroom polysaccharide-peptides against fatty liver injury and the mechanisms involved
Shuang Zhao, Shuman Zhang, Weiwei Zhang, Yi Gao, Chengbo Rong, Hexiang Wang, Yu Liu, Jack Ho Wong, Tzibun Ng
Scientific Reports.2019;[Epub]     CrossRef
Applying Non-Invasive Fibrosis Measurements in NAFLD/NASH: Progress to Date
Somaya Albhaisi, Arun J. Sanyal
Pharmaceutical Medicine.2019; 33(6): 451.     CrossRef
Adiponectin rs2241766 and rs266729 gene polymorphisms in non-alcoholic fatty liver disease
Aida A. Mahmoud, Hoda M. Moghazy, Laila M. Yousef, Asmaa N. Mohammad
Gene Reports.2019; 15: 100381.     CrossRef
Non-invasive diagnosis of non-alcoholic steatohepatitis and fibrosis with the use of omics and supervised learning: A proof of concept study
Nikolaos Perakakis, Stergios A. Polyzos, Alireza Yazdani, Aleix Sala-Vila, Jannis Kountouras, Athanasios D. Anastasilakis, Christos S. Mantzoros
Metabolism.2019; 101: 154005.     CrossRef
Association between Helicobacter pylori infection and nonalcoholic fatty liver
Rongqiang Liu, Qiuli Liu, Ying He, Wenqing Shi, Qianhui Xu, Qing Yuan, Qi Lin, Biao Li, Lei Ye, Youlan Min, Peiwen Zhu, Yi Shao
Medicine.2019; 98(44): e17781.     CrossRef
Nataliia Matkovska, Nataliia Virstiuk, Uliana Balan
International Academy Journal Web of Scholar.2019; (6(36)): 17.     CrossRef
Non-alcoholic fatty liver disease and colorectal cancer: A marker of risk or common causation?
Niki Katsiki, Dimitri P. Mikhailidis, Christos Mantzoros
Metabolism.2018; 87: A10.     CrossRef
Critical Roles of microRNAs in the Pathogenesis of Fatty Liver: New Advances, Challenges, and Potential Directions
Chenggui Miao, Zhongwen Xie, Jun Chang
Biochemical Genetics.2018; 56(5): 423.     CrossRef
Alpha-syntrophin dependent expression of tubulin alpha 8 protein in hepatocytes
Lisa Rein-Fischboeck, Ganimete Bajraktari, Rebekka Pohl, Susanne Feder, Kristina Eisinger, Wolfgang Mages, Elisabeth M. Haberl, Christa Buechler
Journal of Physiology and Biochemistry.2018; 74(4): 511.     CrossRef
Pathogenesis of Nonalcoholic Steatohepatitis and Hormone-Based Therapeutic Approaches
Kook Hwan Kim, Myung-Shik Lee
Frontiers in Endocrinology.2018;[Epub]     CrossRef
Helicobacter pyloriand extragastric diseases: A review
Antonietta Gerarda Gravina, Rocco Maurizio Zagari, Cristiana De Musis, Lorenzo Romano, Carmelina Loguercio, Marco Romano
World Journal of Gastroenterology.2018; 24(29): 3204.     CrossRef
Thiazolidinedione induces a therapeutic effect on hepatosteatosis by regulating stearoyl‑CoA desaturase‑1, lipase activity, leptin and resistin
Hessah Al‑Muzafar, Kamal Amin
Experimental and Therapeutic Medicine.2018;[Epub]     CrossRef
Impact of weight cycling on CTRP3 expression, adipose tissue inflammation and insulin sensitivity in C57BL/6J mice
Xin Li, Li Jiang, Miao Yang, Yu‑Wen Wu, Jia‑Zhong Sun
Experimental and Therapeutic Medicine.2018;[Epub]     CrossRef
Analysis of non‑alcoholic fatty liver disease microRNA expression spectra in rat liver tissues
Jiao Nie, Chang‑Ping Li, Jue‑Hong Li, Xia Chen, Xiaoling Zhong
Molecular Medicine Reports.2018;[Epub]     CrossRef